Codes / ICD10CM / T82.827S

T82.827S Fibrosis due to cardiac prosthetic devices, implants and grafts, sequela

ICD10CM code

ICD10CM

Chat with GenHealth to automate any coding or chart task.

Name of the Condition

Fibrosis due to cardiac prosthetic devices, implants and grafts, sequela

Summary

Fibrosis due to cardiac prosthetic devices, implants, and grafts, sequela, refers to the residual effects of scar tissue formation around implanted cardiac devices that persist after the acute phase of the condition. This sequela may affect device function, surrounding cardiac tissue, or overall cardiac performance, requiring ongoing clinical evaluation and management.

Causes

Fibrosis in this context is primarily triggered by the body's response to foreign materials, such as cardiac prosthetic devices, implants, or grafts. This reaction leads to scar tissue (fibrosis) formation around the device, which may persist as a sequela after the initial event.

Risk Factors

  • Previous cardiac device implantation or graft placement
  • History of surgeries involving cardiac implants
  • Underlying chronic inflammatory conditions
  • Prolonged device use or repeated interventions

Symptoms

  • Persistent pain or tenderness around the implant site
  • Swelling or skin changes over the affected area
  • Reduced effectiveness of the cardiac prosthetic device
  • Changes in cardiac function or symptoms (e.g., shortness of breath, fatigue)

Diagnosis

Diagnosis involves clinical assessment, imaging (e.g., echocardiography, MRI, or CT) to visualize residual fibrosis and device integrity, and laboratory tests to evaluate cardiac function or signs of ongoing inflammation. Documentation should specify the nature of the sequela and its impact on the device or cardiac system.

Treatment Options

  • Anti-inflammatory medications to manage persistent inflammation
  • Device monitoring or re-intervention if function is compromised
  • Cardiac rehabilitation to support overall function

Prognosis and Follow-Up

Prognosis depends on the extent of fibrosis, device function, and cardiac health. Regular follow-up with imaging and clinical assessments is essential to monitor for complications or changes in device performance.

Complications

  • Impaired device function or failure
  • Reduced cardiac output or heart failure
  • Increased risk of infection or thrombosis

Lifestyle & Prevention

  • Adhere to prescribed cardiac monitoring and follow-up schedules
  • Report new or worsening symptoms promptly
  • Maintain overall cardiovascular health through lifestyle modifications

When to Seek Professional Help

Seek medical attention if experiencing persistent pain, swelling, shortness of breath, or signs of device malfunction.

Tips for Medical Coders

Document the sequela of fibrosis due to cardiac prosthetic devices, implants, and grafts clearly, specifying the impact on device function or cardiac tissue. Ensure the code T82.827S is used for sequela, with appropriate clinical details to support the diagnosis.

Book a walkthrough

T82.827S policy automation walkthrough

Walk through the policies, prior authorization requirements, and workflow automation opportunities connected to this code.